Page 14 - Markets

Modern Diagnostic IPO opens on Dec 31: Check GMP, key dates, price band

Modern Diagnostic IPO is being offered at a price band of ₹85 to ₹90 per share, with a lot size of 1,600 shares

JBM Auto jumps 6% on heavy volume amid Fortum EV deal buzz

The National Stock Exchange (NSE) has sought clarification from JBM Auto Limited regarding the news of JBM Auto buying stakes in Fortum' electric-vehicle charging network

New Year picks 2026: Motilal Oswal Wealth bets on Airtel, SBI, Eternal

New Year picks 2026: Motilal Oswal Wealth Management has picked SBI, Airtel, Biocon, Eternal and others for the upcoming year; check details here

Dhara Rail Projects to list on Dec 31: Here's what latest GMP hints at

Ahead of its listing, Dhara Rail's unlisted shares were trading at ₹140.5 per share, commanding a GMP of ₹14.5 or 11.5 per cent over the upper end of the price band of ₹120 to ₹126

Cupid hits all-time high as board nods setting up FMCG unit in Saudi Arabia

Cupid's stock was in demand after the company's board approved setting up FMCG facility in Saudi Arabia

Silver Touch Tech up 7%, hits all-time high; here's what's boosting rally

Silver Touch Technologies shares were in demand after the company was selected as the Digital Transformation Partner for the Indian Navy under the IPADSV2 initiative

Deccan Gold Mines share price tumbles nearly 10% post rights issue

Deccan Gold Mines share price fell nearly 10 per cent after selling pressure increased as the stock struggled to recover above its long-term support levels.

Blackstone-backed Horizon Industrial Parks files DRHP for ₹2,600-cr IPO

Horizon Industrial Parks raised $200 million in the pre-IPO funding round from 360 ONE, SBI Life Insurance, State Bank of India, Radhakishan Damani, EAAA, DSP Investments, among others

Mangalam Drugs & Organics shares hits 5% upper circuit; here's why

On Monday, according to the National Stock Exchange (NSE) bulk deal data, Kedia Securities, headed by Vijay Kedia, purchased 1,37,794 shares at ₹24.15 per share

Ajanta Pharma shares up 3% as Biocon tie-up fuels long-term growth optimism

Ajanta Pharma shares gained 3% despite a weak market as analysts turned bullish on its Biocon partnership, semaglutide opportunity, and growth outlook

Gujarat Kidney makes positive D-St debut; lists at 6% premium on bourses

Gujarat Kidney shares began trading at ₹120.75 per share, a premium of ₹6.75 per share or 6 per cent over the issue price

Shriram Finance shares rise 2% on ratings upgrade; up 13% in a month

The buying on the counter came after Care Ratings upgraded its stance on the company's non-convertible debentures and subordinated debt

Skipper newly rated 'Buy' at Systematix; 17% upside potential seen

Skipper is among the top 10 transmission tower manufacturers globally and has built a strong cost advantage through high backward integration, sourcing nearly 90 per cent of its raw materials in-house

Nifty F&O expiry: Analysts see 26,000 as key resistance; strategy today

The derivatives data reflects at a cautious and guarded market stance, with Call writers at slight advantage, explains Dhupesh Dhameja, Derivatives Research Analyst, SAMCO Securities.

Gold, Silver outlook for 2026: Precious metals brace for consolidation

After a record rally in 2025, will gold and silver sustain gains in 2026? Analysts flag consolidation, price targets, risks and investor strategy

India 2025 IPOs: Record listings, mixed returns; check top winners, losers

Around 70 per cent of the 102 firms that went public this year finished their first trading session in positive territory, data showed

Stocks to Watch today: BEL, RVNL, Waaree Energies, Lemon Tree, IndiGo, RIL

Stocks to watch today, December 30, 2025: Bharat Electronics, Rail Vikas Nigam, Waaree Energies, and Lemon Tree Hotels shares will likely be in focus in Tuesday's session

Motilal Oswal sector of the week: Oil & gas; check top bets, target here

According to Motilal Oswal Financial Services, the sector has also benefited from a series of regulatory and taxation reforms aimed at improving affordability and project viability

Why capping Sebi's surplus risks weakening India's market regulator

Capping Sebi's surplus under the Securities Markets Code risks eroding the regulator's financial autonomy and independence, with implications for market governance and investor confidence in India

Markets slip on FPI selling, year-end listlessness; Sensex down 346 points

Indian equities fell amid year-end listlessness and foreign portfolio investor selling. Sensex declined 0.4% to 84,696, while Nifty fell 0.4% to 25,926